北京协和医院关于“新型冠状病毒感染的肺炎”诊疗建议方案(V2.0)Diagnosis and Clinical Management of 2019 Novel Coronavirus(2019-nCoV) Infection: An Operational Recommendation of Peking Union Medical College Hospital(V2.0)
李太生;曹玮;翁利;范洪伟;施举红;
Working Group of 2019 Novel Coronavirus,Peking Union Medical College Hospital;
摘要(Abstract)：
2019年12月以来,我国陆续出现2019新型冠状病毒(2019 novel coronavirus,2019-nCoV)感染引起的以肺部病变为主的新型传染病。临床特征包括发热、干咳、气促,以及胸部X线检查显示炎症性改变等。我国已将2019-nCoV感染的肺炎定为法定传染病。为规范这一新发突发传染病的诊疗,北京协和医院特制订2019-nCoV感染的肺炎诊疗建议方案。
Since December 2019, China has been experiencing an outbreak of a new infectious disease caused by 2019 novel coronavirus(2019-nCoV). The clinical features include fever, coughing, shortness of breath, and inflammatory lung infiltration. China rapidly listed 2019-nCoV-related pneumonia as a statutory infectious disease. To standardize the diagnosis and treatment of this new infectious disease, an operational recommendation for the diagnosis and management of 2019-nCoV infection is developed by Peking Union Medical College Hospital.
关键词(KeyWords)：
新型冠状病毒;肺炎;诊断;治疗
2019 novel coronavirus;pneumonia;diagnosis;treatment
基金项目(Foundation):
作者(Authors):
李太生;曹玮;翁利;范洪伟;施举红;
Working Group of 2019 Novel Coronavirus,Peking Union Medical College Hospital;
参考文献(References)：
- [1] 国家卫生健康委员会办公厅.新型冠状病毒感染的肺炎诊疗方案(试行第三版)[EB/OL].(2020- 01- 23).http://www.nhc.gov.cn/yzygj/s7653p/202001/f492c9153 ea9437bb587ce2f-fcbee1fa/files/39e7578d85964dbe81117736 dd789d8f.pdf.
- [2] World Health Organization.Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection issuspected[EB/OL].https://www.who.int/internal-publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.
- [3] Li TS,Qiu ZF,Han Y,et al.Rapid loss of both CD4 and CD8 T lymphocyte subsets during the acute phase of severe acute respiratory syndrome[J].Chin Med J,2003,116:985- 987.
- [4] 李太生,邱志峰,韩扬,等.严重急性呼吸综合症急性期T淋巴细胞亚群异常改变[J].中华检验医学杂志,2003,26:297- 299.
- [5] 耿陶然,韩扬,李太生,等.重症流感患者T淋巴细胞与预后研究[J].中华内科杂志,2020,59:200- 206.
- [6] Mori I,Parizot C,Dorgham K,et al.Prominent plasma-cytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome[J].PLoS One,2008,3:e2109.
- [7] Hemming VG.Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases[J].Clin Diagn Lab Immunol,2001,8:859- 863.